SEPN
Biotechnology · Healthcare
Equibles does not estimate personal net worth.
Get an email with a short summary when Septerna, Inc. publishes a filing, an earnings call transcript or a press release.
Get SEPN alertsThe proxy statement of Septerna, Inc. reports total compensation of $1,869,558 for Jae B. Kim in fiscal 2024, including a base salary of $125,057. Jae B. Kim has spoken on 1 earnings call across 1 company, most recently for Septerna, Inc. on March 2, 2026. Septerna, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Septerna, Inc. includes Jeffrey Finer (CEO), Gil M. Labrucherie (CFO), Liz Bhatt (COO) and 3 others.
“I'm excited to present these results from yesterday's late-breaking poster at Quad AI. Turning to the Phase I study design, we conducted a randomized double-blind placebo-control study that included single ascending dose, multiple ascending dose, and open-label crossover food effect cohorts.”
Proxy statement
Start not stated–present
Last confirmed April 30, 2026
Proxy statement
Start not stated–2024-04-25
Last confirmed by a filing; no departure on record
SEPN
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Septerna, Inc. (SEPN) | Chief Medical Officer | $125,057 | $1,869,558 |
| 2024 | Design Therapeutics, Inc. (DSGN) | Former Chief Medical Officer | $362,701 | $710,651 |